Suppr超能文献

β-肾上腺素能阻滞剂:它们的当前状况。

Beta-adrenergic blocking agents: their current status.

作者信息

Clark B K

出版信息

AACN Clin Issues Crit Care Nurs. 1992 May;3(2):447-60. doi: 10.4037/15597768-1992-2016.

Abstract

Use of beta (beta)-adrenergic blocking agents began in the 1960s and has risen dramatically since then. Newer agents offer more actions and fewer side effects. Uses for the drugs continue to increase as their safety and efficacy become increasingly apparent. beta block, today, has widespread application in cardiovascular disease. In addition, these agents are used in the management of endocrine disorders, neurologic situations, psychiatric disorders, gastrointestinal problems, and sensory disorders. Many new beta blockers are still investigational, and some show even greater promise for therapeutic applications in the future.

摘要

β-肾上腺素能阻滞剂的使用始于20世纪60年代,自那时起显著增加。新型药物具有更多作用且副作用更少。随着其安全性和有效性日益明显,这些药物的用途持续增加。如今,β受体阻滞剂在心血管疾病中有着广泛应用。此外,这些药物还用于治疗内分泌失调、神经系统疾病、精神障碍、胃肠道问题和感觉障碍。许多新型β受体阻滞剂仍在研究中,有些在未来的治疗应用中显示出更大的前景。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验